Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Management strategies for female patients of reproductive potential with multiple sclerosis: An evidence-based review

Research output: Contribution to journalReviewResearchpeer-review

  1. Illegal cannabis use is common among Danes with multiple sclerosis

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Worsening of disability caused by relapses in multiple sclerosis: A different approach

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Effect of cladribine tablets on lymphocyte reduction and repopulation dynamics in patients with relapsing multiple sclerosis

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Author response: Nationwide prevalence and incidence study of neuromyelitis optica spectrum disorder in Denmark

    Research output: Contribution to journalComment/debateResearchpeer-review

  2. Alcohol consumption in adolescence is associated with a lower risk of multiple sclerosis in a Danish cohort

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Changes in the sex ratio are a good indicator of changes in MS incidence - No

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Illegal cannabis use is common among Danes with multiple sclerosis

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Multiple sclerosis (MS) is an inflammatory, demyelinating, neurodegenerative, immune-mediated disease primarily diagnosed in early adulthood. Multiple sclerosis mostly impacts women of reproductive potential, with pregnancy and birth outcomes being major concerns for many patients. While there is ample evidence that the disease itself has no impact on pregnancy, many women living with MS still question their ability to have children, and the impact of childbearing on their disease in the short and long term. Such questions emphasize the importance of proper guidance from healthcare professionals, particularly neurologists. Management considerations are also complicated by the growing list of available treatment options. This review will summarize current evidence and expert opinion around the management of female MS patients of reproductive potential, from family planning to the postpartum period. Current guidelines on the use of disease-modifying therapies throughout pregnancy will be discussed, as well as other general medical recommendations, to minimize MS disease activity in the peripartum period.

Original languageEnglish
JournalMultiple Sclerosis and Related Disorders
Volume32
Pages (from-to)54-63
Number of pages10
ISSN2211-0348
DOIs
Publication statusPublished - Jul 2019

    Research areas

  • Disease Management, Evidence-Based Medicine/methods, Family Planning Services/methods, Female, Humans, Multiple Sclerosis/epidemiology, Pregnancy, Pregnancy Complications/epidemiology, Reproduction/physiology

ID: 58904395